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The aim of this studywas to evaluate the influence of the bioactive nonpolar fraction of geopropolis on Streptococcusmutans biofilm.
The ethanolic extract of Melipona scutellaris geopropolis was subjected to a liquid-liquid partition, thus obtaining the bioactive
hexane fraction (HF) possessing antimicrobial activity. The effects of HF on S. mutans UA159 biofilms generated on saliva-coated
hydroxyapatite discs were analyzed by inhibition of formation, killing assay, and glycolytic pH-drop assays. Furthermore, biofilms
treatedwith vehicle control andHFwere analyzed by scanning electronmicroscopy (SEM).HF at 250 𝜇g/mL and 400𝜇g/mL caused
38% and 53% reduction in the biomass of biofilm, respectively, when compared to vehicle control (𝑃 < 0.05) subsequently observed
at SEM images, and this reduction was noticed in the amounts of extracellular alkali-soluble glucans, intracellular iodophilic
polysaccharides, and proteins. In addition, the S. mutans viability (killing assay) and acid production by glycolytic pH drop were
not affected (𝑃 > 0.05). In conclusion, the bioactive HF of geopropolis was promising to control the S. mutans biofilm formation,
without affecting the microbial population but interfering with its structure by reducing the biochemical content of biofilmmatrix.
1. Introduction
Dental caries is a biofilm-related infectious disease and is
still the most prevalent oral disease [1]. Dental decay results
mainly from the interaction between microorganisms in
the mouth, tooth surface, and dietary components of the
host, especially fermentable carbohydrates [2]. Among the
microorganisms present in the complex oral microbiota,
Streptococcus mutans has generally been regarded as the
major etiologic agent of dental caries due to its ability to
initiate the pathogenic biofilm formation [3].
The key role of S. mutans in the origin and installation of
decay is due to its physiological characteristics that allow it
to metabolize fermentable substrates, leading to pathological
conditions observed in the disease. One of the important
virulence factors of this microorganism is the glucan produc-
tion from sucrose by enzymes known as glucosyltransferases
(GTFs). These polysaccharides, particularly the insoluble
ones, are responsible for the extracellular adhesion of bacteria
to the tooth surface in the initial stages of the onset of the
disease. Furthermore, these polysaccharides are responsible
for forming a complex biofilm matrix, providing stability to
thismicrobial community, and providing resistance to certain
antimicrobial agents, as they can be used as energy storage
[4–6]. Another important virulence factor is the ability of S.
mutans to produce acid from fermentable substrates and also
to survive in a low pH environment [7]. Environmental low-
pH is responsible for enamel demineralization by dissolving
the hydroxyapatite crystals present on tooth surface, thus
initiating the pathological process of caries [8].
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Although some strategies have been used in dental caries
control, like fluoride and chlorhexidine digluconate, many
compounds have shown promising activity on the virulence
factors of this microorganism, providing new alternatives in
the treatment and prevention of this disease [9]. Among these
new alternatives, natural products have great merit, since
approximately 70% of new antimicrobials available between
1981 and 2002 derived from natural sources [10].
Propolis is a natural plant resin collected by bees, and
many studies have described its wide range of pharmaco-
logical effects, including activity against virulence factors
of S. mutans [11–15]. Furthermore, some bioactive com-
pounds isolated from Brazilian honeybee propolis have
shown inhibitory capabilities in the development of caries in
in vivo models [16]. Most studies on the biological activity
and chemical composition provide added economic value
to various types of propolis produced by the Apis mellifera
bee, while others remain without a detailed description of
their chemical composition and pharmacological activity.
Among the several kinds of propolis, geopropolis is a different
type collected by native and threatened stingless bees, such
as Melipona scutellaris. Geopropolis is a kind of propolis
composed by resin, wax, and soil collected by bee and
deposited inside the beehive. It is widely used in theNortheast
Region of Brazil although it has no added value [17].However,
there are few studies on this type of propolis, regarding
its biological and chemical properties, describing its anti-
inflammatory, antinociceptive, and antimicrobial activities,
and also presenting polyprenylated benzophenones as major
compounds instead of flavonoids, commonly found in other
types of propolis [18–20]. Therefore, further studies on its
biological activity are needed to add value to this product
and elucidate its potential as a source of new bioactive
compounds.The interesting potential of geopropolis has been
reported by our research group, especially its hexane fraction,
against oral bacteria [20]. Thus, the aim of this study was to
investigate the influence of the hexane fraction of ethanolic
extract of geopropolis on in vitro S. mutans biofilm.
2. Material and Methods
2.1. Propolis Samples and Fractionation. Crude samples of
geopropolis from M. scutellaris (native stingless bee) were
obtained from the city of Entre Rios (11∘57󸀠 S, 38∘05󸀠W), in
the state of Bahia, Northeast Brazil. Samples were extracted
using ethanol (1 : 7, w/v) and dried according to Franchin
et al. [18]. The ethanolic extract of geopropolis (EEGP)
was subjected to chemical fractionation by a liquid-liquid
extraction, based on a polarity gradient [18]. The liquid-
liquid fractionation of the EEGP was carried out using three
organic solvents, following the sequence: hexane (1 : 1, v/v) →
chloroform (1 : 1, v/v) → ethyl acetate (1 : 1, v/v). After
concentration, each fractionwas tested against S.mutans, and
hexane fraction (HF) was selected for presenting the highest
antimicrobial activity required to proceed with the bioguided
fractionation [20, 21]. Before using it, the HF was recon-
stituted with absolute ethanol at 3.2% (w/v) concentrations
based on minimal inhibitory concentration for S. mutans.
2.2. Biofilm Assays. Biofilms of S. mutans UA159 (ATCC
700610, serotype c) were formed on saliva-coated hydrox-
yapatite (sHA) disks (Clarkson Chromatography Products,
Inc., South Williamsport, PA; surface area 1.47 cm2). Human
whole saliva was collected from one donor (Research Ethics
Committee of the School of Dentistry of Piracicaba—
University of Campinas—Protocol no. 047/2011), clarified by
centrifugation (10000 g, 4∘C, 10min), sterilized and diluted
(1 : 1) in adsorption buffer (AB—50mM KCl, 1mM KPO
4
,
1 mM CaCl
2
, 0.1mM MgCl
2
, pH 6.5), and supplemented
with the protease inhibitor phenylmethylsulfonyl-fluoride
(PMSF) at a final concentration of 1mmol/L. The sHA disks
were placed in a vertical position, in 24-well plates, and
inoculated with approximately 2 × 106 CFU/mL in buffered
ultrafiltered (10 kDa cutoff membrane; Prep/Scale; Millipore,
MA) tryptone yeast extract (UFTYE, pH 7.0), with the
addition of 1% (w/v) sucrose, at 37∘C, 5% CO
2
. The biofilms
were initially grown undisturbed during 24 hours, and then
the culture medium was replaced daily during the 5 days of
each experiment (total 115 h), according to Koo et al. [22].
The influence of the treatments with HF or vehicle control
(ethanol 12.5%) on biofilm was analyzed according to the
experimental scheme shown in Figure 1.
2.3. Inhibition of Biofilm Formation. To assess the effect of
hexane fraction of geopropolis on the S. mutans biofilm
formation, 24 h-old biofilms were treated twice daily (10 a.m.
and 4 p.m., total of eight treatments, 1min exposure each)
with hexane fraction of geopropolis (250 and 400𝜇g/mL) or
vehicle control (ethanol 12.5%, v/v); both diluted in sterile AB
(Figure 1(a)). The biofilms were washed five times in sterile
saline 0.9%NaCl (to remove nonadhered cells), exposed dur-
ing one minute to the agents, double washed in sterile saline
0.9% (to eliminate carry over effect), and finally returned to
the culture medium. At the end of the experimental period
(115 h) for biochemical collection data, the biofilms were
removed and were subjected to ultrasound bath, sonication
(30 s pulse; output 7W), to provide themaximumrecoverable
viable counts. The homogenized suspension was analyzed
for biomass (dry weight), bacterial viability (colony forming
units CFU/mL), polysaccharide, and protein content. The
extracellular water soluble polysaccharides (WSP), alkali-
soluble polysaccharides (IP), and intracellular iodophilic
polysaccharides (IPS) were extracted and quantified by col-
orimetric assays as detailed by Koo et al. [22] and Duarte et
al. [23]; the exopolysaccharides were quantified by the phe-
nolsulfuric method using glucose as standard [24], whereas
IPSwas quantified using 0.2% I2/2%KI solution and glycogen
as standard, as described by DiPersio et al. [25]. The total
protein was determined by colorimetric assays as detailed by
Smith et al. [26].
2.4. Scanning Electron Microscopy (SEM). For SEM analysis,
the 115 h-old biofilm (treated as described in the inhibition
of biofilm formation, Figure 1(a)) were washed in sterile
NaCl 0.9% and then fixed with a 4% glutaraldehyde (v/v, in
(phosphate buffered saline PBS, pH 7.4)) solution for 24 h.
After that, biofilms were dehydrated in graded ethanol series
(50, 70, 90, and 100%), dried for 24 h, and sputter coated with
Evidence-Based Complementary and Alternative Medicine 3
Table 1: Effect of geopropolis fraction on the biochemical composition and viability of biofilm of 𝑆. 𝑚𝑢𝑡𝑎𝑛𝑠.
Treatment
Mean (±SD)
DW ASP IPS WSP Protein BV
(mg) (𝜇g) (𝜇g) (𝜇g) (mg) (log CFU/mL)
Vehicle (Ethanol 12.5%) 4.63 (±0.59) 820.0 (±82.4) 289.9 (±44.9) 94.9 (±31.2) 1.14 (±0.20) 7.44 (±0.20)
HF 250 𝜇g/mL 2.83 (±0.88)∗ 403.3 (±70.0)∗ 73.6 (±19.6)∗ 75.3 (±25.2) 0.50 (±0.12)∗ 7.56 (±0.16)
HF 400𝜇g/mL 2.18 (±0.28)∗ 352.2 (±62.1)∗ 52.4 (±05.7)∗ 72.2 (±31.3) 0.48 (±0.06)∗ 7.62 (±0.27)
∗P < 0.05 when compared to vehicle control (ANOVA, Tukey-Kramer). DW: dry weight; ASP: alkali-soluble polysaccharide; IPS: intracellular iodophilic
polysaccharide; WSP: water soluble polysaccharide; BV: bacterial viability.
Day 0 Day 5Day 1–4
24h
UndisturbedS. mutans
inoculum
- Inhibition of formation
- SEM10 a.m. treatment
4 p.m. treatment
8 a.m. medium replacement
(a)
Day 0 Day 5Day 1–4
24h
Undisturbed Exposure to HF/vehicle:S. mutans
inoculum - Time kill
- pH drop
8 a.m. medium replacement
(b)
Figure 1: Experimental scheme of biofilm treatments. (a) Biofilms were treated withHF or vehicle control (ethanol 12.5%) twice daily after the
initial 24 h, and then at the 5th day, the biofilms were analyzed by inhibition of formation experiment and by scanning electron microscopy
(SEM). (b) Biofilms were grown with no treatment until the 5th day, and then the biofilms were exposed to HF or vehicle according to the
experimental protocols of time kill and pH drop assays.
gold-palladium. The samples were then analyzed by SEM
(JSM 5600LV, JEOL Tokyo, Japan) at 7000x [27].
2.5. Killing Assay. For the killing assay, 115 h-old biofilms
(without treatment, Figure 1(b)) were exposed to HF at 250
and 400 𝜇g/mL, vehicle (ethanol 12.5%), and positive control
(chlorhexidine digluconate 0.12%, Sigma-Adrich). At specific
times (30, 60, 90, and 120min) after exposure, biofilms were
removed by ultrasound bath, sonication (30 s pulse; output
7W), and then the homogenized suspension was serially
diluted and plated on BrainHeart Agar. Plates were incubated
in 5% CO
2
, at 37∘C, for 48 h, and the number of colonies was
determined (CFU/mL). Killing curves were constructed by
plotting log 10 CFU/mL versus time over 120min [16].
2.6. Glycolytic pH Drop. The effect of test agents on the acid
production by S. mutans biofilms was evaluated using a tech-
nique described by Belli et al. [28] with some modifications.
The 115 h-old biofilms grown in sHA disks (without daily
treatments, Figure 1(b)) were washed in salt solution (50mM
KCl, 1mMMgCl
2
⋅6H
2
O, pH 7.0) and exposed toHF (250 and
400𝜇g/mL) or vehicle control (12.5% ethanol) for 90min.The
pHs of these solutions were adjusted to 7.2 with 0.1M KOH
solution, and then glucose was added (final concentration 1%,
w/v). The decrease in pH was monitored with an Orion pH
glass electrode attached to an Orion 290 A+ pHmeter.
2.7. Statistical Analysis. All assays were performed in dupli-
cate of three independent experiments (𝑛 = 6). The data were
subjected to the Shapiro-Wilk test followed by ANOVA and
the Tukey-Kramer test to adjust for multiple comparisons,
using the Biostat software version 5.0 for statistical visualiza-
tion. The significance level was set at 5%.
3. Results
Table 1 shows the influence of bioactive HF of geopropolis on
S. mutans biofilm formation on saliva-coated hydroxyapatite
surface. The HF was not able to reduce the recoverable
viable cells when compared to the vehicle control (𝑃 >
0.05). However, it significantly reduced the formation and
accumulation of S. mutans biomass (𝑃 < 0.05) when
compared with the ones treated with vehicle. Treatment
with HF at 250𝜇g/mL reduced 38% of biomass (dry weight)
when compared to vehicle treatment, whereas the treatment
with HF at 400𝜇g/mL promoted a reduction of 53%. The
biofilms treated with HF exhibited approximately 50–80%
less polysaccharide than those treatedwith the vehicle control
(𝑃 < 0.05). Except for the water soluble polysaccharide
(WSP), the other kinds of glucans analyzed in this study had
a significantly lower value than the vehicle control in biofilms
treated with HF at both concentrations. Furthermore, the
treatments also reduced significantly the total amount of
protein in the biofilm, when compared to the vehicle control
(𝑃 < 0.05).
SEM images (Figure 2) show the effect of HF at 250
and 400𝜇g/mL on the biofilm accumulation. The images
4 Evidence-Based Complementary and Alternative Medicine
(a) (b) (c)
Figure 2: Effect of hexane fraction of geopropolis on the biofilm of S. mutans. (a) Vehicle control, (b) 250 𝜇g/mL, and (c) 400𝜇g/mL.
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Figure 3: Time-kill curves of the hexane fraction on S. mutans
biofilm.
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Figure 4: Influence of the hexane fraction and vehicle on glycolytic
pH-drop in S. mutans biofilm.
indicate a reduction of biomass accumulation by reducing the
extracellular matrix without affecting the S. mutans growth.
Figure 3 shows that HF, at 250𝜇g/mL and 400𝜇g/mL,
was able to reduce the cell viability of S. mutans on 115 h-old
biofilm, but not significantly (𝑃 > 0.05). Furthermore, the
acid production of S. mutans was not affected by HF at both
concentrations (𝑃 > 0.05) (Figure 4), in the same condition
(Figure 1(b)) once the treatments showed no difference from
vehicle control. Thus, the HF was unable to interfere in the
glycolytic production of acid by S. mutans biofilm which
means that after the addition of glucose the HF did not
prevent the drop in the curve of pH/acid production of the
biofilm (Figure 4).
4. Discussion
Dental caries is a multifactorial disease, and its origin is
associated to certain bacteria, especially S. mutans, which
is responsible for initiating the cariogenic biofilm [1]. Thus,
some alternative strategies to combat decay are focused
on the control of the biofilm formed by this organism,
acting on its virulence factors such as acidogenicity and
polysaccharide formation [9]. Natural products have proved
to be an important source of compounds that can act on these
targets. Among these products, propolis has been noted for
its known action on S. mutans, but geopropolis, a different
kind of propolis, had not been studied yet on its ability
to control the virulence factors of this microorganism. The
aim of this study was to evaluate the activity of the hexane
fraction from the ethanolic extract ofM. scutellaris (stingless
bee) geopropolis on in vitro S. mutans UA159 biofilm (ATCC
700610) and some of its virulence factors. Liberio et al. [29]
recently studied the Melipona fasciculata geopropolis of the
State of Maranha˜o (Northeast Brazil) from different biomes;
however, their study differs from ours because its focus is on
the viability of S. mutans ATCC 25175.
Geopropolis fromM. scutellaris is active against S.mutans
UA159 grown in planktonic state, and the nonpolar fraction
(hexane) was selected because it has the highest activity
among all fractions tested. In addition, the ethanolic extract
of geopropolis and its HF significantly reduced cell adherence
on in vitro biofilm [20]. In this study, HF of ethanolic extract
of geopropolis was able to reduce the biomass (dry weight)
compared to vehicle control (𝑃 < 0.05) when treated twice
daily (total of eight treatments). We observed no decrease in
the number of viable cells of S. mutans, suggesting a possible
action on the biofilm matrix produced by this microorgan-
ism.However, the analyses of the biochemical composition of
the biofilm indicated a significant reduction in the amounts of
polysaccharides and protein. The interference on the matrix
formation by HF led to a structural shift in the matrix, as
these biochemical compounds are responsible for a three-
dimensional conformation of the biofilm [30]. Confirming
the action on the matrix, SEM images (Figure 2) showed
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a qualitative change in the structure and organization of the
biofilm, as well as a loss of surface homogeneity.The apparent
loss of homogeneity could be due to a simple superficial
rearrangement, but the biochemical content data corroborate
the hypothesis that HF promoted a lower accumulation of
glucans and proteins in the matrix, when compared to the
vehicle control.
As HF was able to significantly reduce the amounts of
proteins and extracellular polysaccharides, this agent showed
an important impact on the accumulation and development
of cariogenic biofilm. These polysaccharides, particularly
insoluble extracellular (alkali-soluble) ones, may represent
more than 40%of the biofilmdryweight, and they are consid-
ered responsible for promoting the binding and accumulation
of microorganisms on the apatitic surface and to each other
[30, 31]. Interfering in the synthesis of these compounds, HF
would be useful in attenuating the mechanically stable struc-
ture formation of the biofilm, which protects the bacteria
from environmental influences [32], including antimicrobial
agents [4]. With these protections affected, the bacteria
would be more susceptible to the host’s defenses, making the
attachment to tooth surface difficult and consequently the
establishment of pathogenic biofilms. Furthermore, a change
in extracellular glucan content of the biofilm caused by HF
could influence the bacteria surface adherence, which would
explain the findings of da Cunha et al. [20] on bacterial cell
adhesion.
Furthermore, a reduction in the amount of IPS was
observed in biofilms treated with HF. These glucans are
glycogen-like storage polymers with 𝛼 1–4 and 𝛼 1–6 linkages
that can be fermented by bacteria under conditions in
which exogenous carbohydrates are absent. The use of these
polysaccharides by S. mutans leads to acid production that
contributes to tooth demineralization [6]. This way, the long
time exposure to HF could attenuate, in part, the pathogenic
effects caused by the cariogenic biofilm.
This reduction on polysaccharide accumulation can be
mainly due to a specific inhibitory activity on bacterial GTF
or by affecting the expression of gtf genes. Among all polysac-
charides analyzed, only the insoluble ones, ASP and IPS, were
significantly inhibited, meanwhile the production WSP was
not affected. The reduction of insoluble polysaccharides can
be explained by a specific enzymatic inhibition of GTF B and
C that produces glucans rich in 𝛼 1–3 and 𝛼 1–6 linkages,
respectively. There was probably no effect on GTF D, which
produces mainly soluble glucans, like WSP.
Besides the analysis of action on biofilm matrix, HF
was evaluated on cellular viability and acid production of S.
mutans. At the concentrations tested in this study, HFwas not
able to affect the S. mutans viability and also had no inter-
ference on glycolytic acid production by the microorganism
since this organism is acidogenic. Both results support the
hypothesis of a selective activity of HF on the production
of glucans by S. mutans, since HFs at these concentrations
were not lethal to the microorganism and had no action
over acid production, other important virulence factor of S.
mutans that leads to superficial demineralization of the dental
enamel by the dissolution of hydroxyapatite. Duarte et al. [16]
showed a similar result for Brazilian propolis type 6, collected
by A. mellifera bee. Although this type (6) of propolis has
affected the acid production of bacteria, it did not affect the
S. mutans UA159 viability, as well as HF in the present study.
Moreover, in another report, Brazilian propolis type 6 was
able to inhibit the S. mutans growth and adherence besides
reducing the GTF activity in solution and adsorbed on sHA
surface. Thereby, it would lead to a decrease in extracellular
polysaccharide production and probably to a reduction on
cell adherence and biofilm biomass, as observed for HF [12].
Such similar results between M. scutellaris geopropolis
andBrazilian propolis type 6 could be explained in part by the
same region of collection of these two varieties of propolis, as
the biome of the collection determines the chemical content
of propolis [33]. Even if collected by different bees, both
products are obtained from the same region of the Atlantic
Forest of the state of Bahia, Northeast Brazil, and according
to preliminary studies from our research group they appear
to have similar chemical profile, as geopropolis essentially has
nonpolar compounds, like polyprenylated benzophenones,
with the absence of flavonoids, as well as described for the
Brazilian propolis type 6, that has hyperibone A as the main
bioactive compound [14, 20].
Liberio et al. [29] evaluated the activity of the hydroal-
coholic extract of geopropolis from M. fasciculata on
oral pathogens. Their results indicated that this extract at
25mg/mL is capable of reducing the viability of S. mutans
(ATCC 25175) on biofilm formed in cell-culture plates. The
different results observed when compared to the present
study can be due to the distinct bacterial strains tested, once S.
mutansATCC25175 is recognized asmore resistant to antimi-
crobials, probably due to a differentiated and accelerated
polysaccharide production in the extracellular matrix [34,
35]. Besides this, the active concentration used (greater than
60 times our highest concentration), the biofilm model (24-
well polystyrene cell-culture plates), and mainly the biome
where these geopropolis were collected (lakes, and babassu
palm forests) can explain such different results. Our study
reports the activity of M. scutellaris geopropolis, collected
in the Atlantic forest, while M. fasciculata geopropolis origi-
nated from an ecosystem composed of mangroves, wetlands,
lakes and babassu palm forests, which probably provides a
different source of plant resins that can alter the geopropolis
chemical composition. Furthermore, previous analyses have
shown thatM. scutellaris geopropolis has no flavonoids, while
the activity ofM. fasciculata geopropolis has been assigned to
the presence of these compounds [20].
Finally, concerning new approaches in antimicrobial
agents, Koo and Jeon [9] describe that natural products that
act on the virulence factors of S. mutans without necessarily
killing the bacteria have attracted attention as important
sources of new effective drugs against dental caries. In the
light of this view, our data show that geopropolis, especially its
nonpolar fraction (hexane fraction), is a promising source of
new compounds like polyprenylated benzophenones, capa-
ble to act on dental caries. Further studies are necessary
to confirm such activity and to isolate/identify the active
compounds.
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5. Conclusion
In summary, the hexane fraction of M. scutellaris (stingless
bee) geopropolis from the Atlantic forest of the state of Bahia
(Northeast Brazil) affected the biofilm formation by reducing
the biomass, the polysaccharides, and protein content of
biofilm matrix. However, it had no effect on the viability and
acid production of S. mutans.This fraction is a natural source
of promising bioactive substances to control the formation
of S. mutans oral biofilm, without affecting the microbial
population but interfering with its structure by reducing the
biochemical content of biofilm matrix.
Although further studies are required to identify the
active compounds and their molecular mechanism of action,
these compounds in HF may also be comprised in new
formulations for clinical trials for oral plaque control, in order
to prevent dental caries and oral biofilm related disease.
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